Table 1.
Comparison between the groups in relation to morphological and cardiovascular variables.
| Overall sample | Normotensive | Hypertensive | |||||||
|---|---|---|---|---|---|---|---|---|---|
| CG (n = 14) | NP (n = 10) | DUP (n = 12) | CG (n = 7) | NP (n = 5) | DUP (n = 6) | CG (n = 7) | NP (n = 5) | DUP (n = 6) | |
| Age (years) | 68.4 ± 5.8 | 67.5 ± 4.4 | 66.7 ± 4.7 | 66.7 ± 4.0 | 66.6 ± 5.3 | 65.0 ± 2.3 | 70.1 ± 6.7 | 66.8 ± 7.7 | 68.5 ± 5.1 |
| BMI (kg/m2) | 25.2 ± 8.0 | 30.3 ± 4.02 | 25.6 ± 4.65 | 29.9 ± 3.8 | 31.5 ± 4.5 | 27.8 ± 6.0 | 20.5 ± 8.2 | 29.3 ± 2.3 | 27.8 ± 6.0 |
| SBP (mmHg) | 138.1 ± 13.7 | 145.1 ± 18.5 | 149.2 ± 22.5 | 128.0 ± 10.2 | 131.4 ± 14.6 | 129.0 ± 13.0 | 146.1 ± 8.7a | 158.8 ± 9.9b | 166.0 ± 12.8c |
| DBP (mmHg) | 80.2 ± 11.6 | 90.5 ± 18.9 | 86.2 ± 8.6 | 76.1 ± 10.1 | 81.0 ± 6.0 | 84.6 ± 6.8 | 84.3 ± 11.5 | 100.0 ± 22.3 | 89.0 ± 8.4 |
| MAP (mmHg) | 99.4 ± 11.3 | 108.7 ± 16.3 | 107.7 ± 11.1 | 93.4 ± 8.8 | 97.8 ± 6.9 | 99.4 ± 8.6 | 104.9 ± 10.3 | 119.6 ± 15.7 | 114.7 ± 7.2 |
| HR (bpm) | 76.5 ± 7.6 | 78.1 ± 10.9 | 71.8 ± 10.1 | 78.4 ± 8.1 | 74.4 ± 7.5 | 71.0 ± 7.0 | 74.6 ± 6.3 | 81.8 ± 12.5 | 72.5 ± 12.1 |
| DP (mmHg.bpm) | 1.0512 ± 1.352 | 11356 ± 2380 | 1.0723 ± 2,208 | 10.021 ± 1.220 | 9.705 ± 921 | 9.237 ± 1.799 | 10.917 ± 1.287 | 13.006 ± 2.244 | 11.961 ± 1.694 |
| Hypertension prevalence (%) | 50 | 50 | 50 | 0 | 0 | 0 | 100 | 100 | 100 |
| DRUG CLASS (%) | |||||||||
| ANG II receptor antagonist | 80 | 80 | 80 | — | — | — | 80 | 80 | 80 |
| ACE inhibitor | 10 | 20 | 0 | — | — | — | 10 | 20 | 0 |
| Diuretic | 10 | 20 | 20 | — | — | — | 10 | 20 | 20 |
| Calcium channel blockers | 0 | 0 | 20 | — | — | — | 0 | 0 | 20 |
Data are presented in mean ± SD.SBP, Systolic blood pressure; DBP, Diastolic blood pressure; MAP, Mean arterial pressure; HR, Heart rate; DP, Double product; NP, Non-periodized; DUP, Daily undulating periodization; CG, Control group; ANG, Angiotensin; ACE, Angiotensin converting enzyme; aP < 0.05 compared to CG in the normotensive sample, bP < 0.05 compared to NP in the normotensive sample, cP < 0.05 compared to DUP in the normotensive sample.